Literature DB >> 14613232

Ex ova chick chorioallantoic membrane as a novel model for evaluation of tissue responses to biomaterials and implants.

Ulrike Klueh1, David I Dorsky, Francis Moussy, Don L Kreutzer.   

Abstract

One of the major obstacles in developing rationale strategies to control inflammation and fibrosis surrounding implants is the lack of a simple and inexpensive in vivo model to screen tissue reactions to various biomaterials and implants. To begin to fill this gap, we have developed an ex ova model of the chick embryo chorioallantoic membrane (CAM) for testing of tissue reaction to biomaterials and implants. For these studies, we evaluated tissue reactions (inflammation and fibrosis) to two commonly used biomaterials (nylon and silastic) grossly and histologically in the ex ova CAM. Nylon mesh was incorporated within the CAM tissue 4 days postplacement. After 8 days postplacement, the nylon mesh was totally incorporated into the CAM. Histologically, little or no inflammation was seen associated with the incorporated nylon mesh at any time point. In the case of silastic tubing, significant incorporation of the CAM was seen grossly by 1-2 days postplacement. Incorporation of the tubing continued at day 8 postplacement of the silastic tubing, with ingrowth of the CAM into the lumen of the tubing. Histological evaluation of CAMs indicated that no significant tissue reactions (inflammation or fibrosis) occurred in the CAM tissue surrounding the silastic tubing or in the CAM tissue and vasculature that had grown into the silastic tubing. To our knowledge, this report represents the first investigation of the usage of the ex ova CAM model, a shell-less chick embryo model (ex ova), as an in vivo model to test the tissue reactions to biomaterials and implants. Copyright 2003 Wiley Periodicals, Inc. J Biomed Mater Res 67A: 838-843, 2003

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14613232     DOI: 10.1002/jbm.a.10059

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  7 in total

1.  Fetal mouse skin heals scarlessly in a chick chorioallantoic membrane model system.

Authors:  Antoine L Carre; Barrett J Larson; Joseph A Knowles; Kenichiro Kawai; Michael T Longaker; H Peter Lorenz
Journal:  Ann Plast Surg       Date:  2012-07       Impact factor: 1.539

Review 2.  The chicken chorioallantoic membrane model in biology, medicine and bioengineering.

Authors:  Patrycja Nowak-Sliwinska; Tatiana Segura; M Luisa Iruela-Arispe
Journal:  Angiogenesis       Date:  2014-08-20       Impact factor: 9.596

Review 3.  Application of the chick embryo chorioallantoic membrane in neurosurgery disease.

Authors:  Yong-Jie Yuan; Kan Xu; Wei Wu; Qi Luo; Jin-Lu Yu
Journal:  Int J Med Sci       Date:  2014-10-27       Impact factor: 3.738

4.  Evaluation of Angiogenesis in an Acellular Porous Biomaterial Based on Polyhydroxybutyrate and Chitosan Using the Chicken Ex Ovo Chorioallantoic Membrane Model.

Authors:  Zuzana Demcisakova; Lenka Luptakova; Zuzana Tirpakova; Alena Kvasilova; Lubomir Medvecky; Ward De Spiegelaere; Eva Petrovova
Journal:  Cancers (Basel)       Date:  2022-08-30       Impact factor: 6.575

5.  Comparison of medetomidine, thiopental and ketamine/midazolam anesthesia in chick embryos for in ovo Magnetic Resonance Imaging free of motion artifacts.

Authors:  Conny Waschkies; Flora Nicholls; Johanna Buschmann
Journal:  Sci Rep       Date:  2015-10-23       Impact factor: 4.379

6.  Tumor grafts grown on the chicken chorioallantoic membrane are distinctively characterized by MRI under functional gas challenge.

Authors:  Conny F Waschkies; Fatma Kivrak Pfiffner; Dorothea M Heuberger; Marcel A Schneider; Yinghua Tian; Petra Wolint; Maurizio Calcagni; Pietro Giovanoli; Johanna Buschmann
Journal:  Sci Rep       Date:  2020-05-05       Impact factor: 4.379

Review 7.  Evolving applications of the egg: chorioallantoic membrane assay and ex vivo organotypic culture of materials for bone tissue engineering.

Authors:  Karen M Marshall; Janos M Kanczler; Richard Oc Oreffo
Journal:  J Tissue Eng       Date:  2020-10-20       Impact factor: 7.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.